A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

NCT02386553 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen